(Q48202023)

9 February 2018

title

Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue (English)

1 reference

9 February 2018

0 references

0 references

1 reference

1

1 reference

9 February 2018

Elly M Hol

6

1 reference

9 February 2018

Inge Huitinga

9

object named as

Inge Huitinga

1 reference

9 February 2018

author name string

Karianne G Schuurman

2

1 reference

9 February 2018

Miriam E van Strien

3

1 reference

9 February 2018

Jeroen Melief

4

1 reference

9 February 2018

Debbie Hendrickx

5

1 reference

9 February 2018

Corbert van Eden

7

1 reference

9 February 2018

Sabina Luchetti

8

1 reference

9 February 2018

publication date

1 February 2013

1 reference

9 February 2018

Journal of Neuropathology & Experimental Neurology

published in

1 reference

9 February 2018

volume

72

1 reference

9 February 2018

issue

2

1 reference

9 February 2018

page(s)

91-105

1 reference

9 February 2018

Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?

cites work

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

Vitamin D in the healthy and inflamed central nervous system: access and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

The immunopathology of multiple sclerosis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

Phenotyping primary human microglia: tight regulation of LPS responsiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

1,25-Dihydroxyvitamin D3 receptors in the central nervous system of the rat embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

1,25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

Vitamin D and risk of cognitive decline in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

Serum vitamin D and the risk of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

Enzymes involved in the activation and inactivation of vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

gamma-Interferon-induced resistance to 1,25-(OH)2 D3 in human monocytes and macrophages: a mechanism for the hypercalcemia of various granulomatoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

Monocyte-derived cells express CYP27A1 and convert vitamin D3 into its active metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

Vitamin D3 inhibits proinflammatory cytokines and nitric oxide production by the EOC13 microglial cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

Differential expression of M-CSF, LIF, and TNF-alpha genes in normal and malignant rat glial cells: regulation by lipopolysaccharide and vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/alpha 2MR, and the receptor-associated protein (RAP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31827F4FCC

10.1097/NEN.0B013E31827F4FCC

21 January 2018

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018